| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
77,921,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
4,773,204 |
Avg
Vol: |
2,204,032 |
| 52
Week Range: |
$81.49 - $81.49 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NASDAQ BIOTECHNOLOGY |
| |
NASDAQ COMPOSITE |
|
S&P 400 MIDCAP |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-15 |
2023-11-14 |
2023-05-16 |
2022-05-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Baldino Frank Jr |
Chairman & CEO |
• • – |
2007-12-19 |
4 |
D |
$73.90 |
$592,826 |
D/D |
(8,022) |
426,031 |
|
- |
|
| Osborn John E |
Exec VP, General Counsel & Sec |
• – – |
2007-12-19 |
4 |
D |
$73.90 |
$111,220 |
D/D |
(1,505) |
47,680 |
|
- |
|
| Grebow Peter E |
Exec. VP, WW Technical Ops. |
• – – |
2007-12-19 |
4 |
D |
$73.90 |
$112,550 |
D/D |
(1,523) |
51,396 |
|
- |
|
| Osborn John E |
Exec VP, General Counsel & Sec |
• – – |
2007-12-17 |
4 |
D |
$74.59 |
$246,893 |
D/D |
(3,310) |
49,185 |
|
- |
|
| Savini Carl A |
Exec. VP & CAO |
• – – |
2007-12-17 |
4 |
D |
$74.59 |
$246,893 |
D/D |
(3,310) |
46,940 |
|
- |
|
| Russell Lesley |
Exec. VP, WW Med & Reg Affairs |
• – – |
2007-12-17 |
4 |
D |
$74.59 |
$12,009 |
D/D |
(161) |
31,995 |
|
- |
|
| Grebow Peter E |
Exec. VP, WW Technical Ops. |
• – – |
2007-12-17 |
4 |
D |
$74.59 |
$256,142 |
D/D |
(3,434) |
52,919 |
|
- |
|
| Roche Robert P Jr |
Exec VP, WW Pharmaceutical Ops |
• – – |
2007-12-17 |
4 |
D |
$74.59 |
$246,893 |
D/D |
(3,310) |
48,899 |
|
- |
|
| Buchi J Kevin |
Exec. Vice President & CFO |
• – – |
2007-12-17 |
4 |
D |
$74.59 |
$265,317 |
D/D |
(3,557) |
84,200 |
|
- |
|
| Vaught Jeffry L |
Exec. VP & Pres., R&D |
• – – |
2007-12-17 |
4 |
D |
$74.59 |
$246,893 |
D/D |
(3,310) |
67,447 |
|
- |
|
| Baldino Frank Jr |
Chairman & CEO |
• • – |
2007-12-17 |
4 |
D |
$74.59 |
$1,308,980 |
D/D |
(17,549) |
435,356 |
|
- |
|
| Russell Lesley |
Exec. VP, WW Med & Reg Affairs |
• – – |
2007-12-13 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
32,156 |
|
- |
|
| Vaught Jeffry L |
Exec. VP & Pres., R&D |
• – – |
2007-12-13 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
70,757 |
|
- |
|
| Savini Carl A |
Exec. VP & CAO |
• – – |
2007-12-13 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
50,250 |
|
- |
|
| Roche Robert P Jr |
Exec VP, WW Pharmaceutical Ops |
• – – |
2007-12-13 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
52,209 |
|
- |
|
| Buchi J Kevin |
Exec. Vice President & CFO |
• – – |
2007-12-13 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
87,757 |
|
- |
|
| Grebow Peter E |
Exec. VP, WW Technical Ops. |
• – – |
2007-12-13 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
56,353 |
|
- |
|
| Osborn John E |
Exec VP, General Counsel & Sec |
• – – |
2007-12-13 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
52,495 |
|
- |
|
| Baldino Frank Jr |
Chairman & CEO |
• • – |
2007-12-13 |
4 |
A |
$0.00 |
$0 |
D/D |
80,000 |
452,905 |
|
- |
|
| Baldassano Valli F. |
Exec VP, Chief Compliance Off. |
• – – |
2007-12-13 |
4 |
A |
$0.00 |
$0 |
D/D |
3,750 |
3,750 |
|
- |
|
| Roche Robert P Jr |
Exec VP, WW Pharmaceutical Ops |
• – – |
2007-12-12 |
4 |
S |
$75.75 |
$1,989,090 |
D/D |
(26,239) |
37,209 |
|
- |
|
| Roche Robert P Jr |
Exec VP, WW Pharmaceutical Ops |
• – – |
2007-12-12 |
4 |
S |
$75.89 |
$603,698 |
D/D |
(7,937) |
63,448 |
|
- |
|
| Roche Robert P Jr |
Exec VP, WW Pharmaceutical Ops |
• – – |
2007-12-12 |
4 |
OE |
$48.06 |
$1,719,708 |
D/D |
34,176 |
71,385 |
|
- |
|
| Baldino Frank Jr |
Chairman & CEO |
• • – |
2007-12-11 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,303 |
434,053 |
|
- |
|
| Buchi J Kevin |
Exec. Vice President & CFO |
• – – |
2007-12-11 |
4 |
GD |
$0.00 |
$0 |
D/D |
80 |
72,757 |
|
- |
|
491 Records found
|
|
Page 9 of 20 |
|
|
